Less-toxic chemo improves outlook for advanced bladder cancer
(Medical Xpress) -- New data from the University of Rochester Medical Center confirms that an easier, two-drug chemotherapy regimen given to bladder cancer patients prior to surgery shrinks locally advanced tumors and completely eliminates all evidence of cancer in some patients.
Published in the journal Cancer, the study is promising news for people diagnosed with Stage 2, 3 or 4 muscle-invading bladder cancers. Typically these patients must decide whether it is best to have surgery immediately, or to try to knock down the malignancy first with pre-surgery chemotherapy. If an individual chooses the latter course, according to scientific literature the most effective regimen is a four-drug cocktail, methotrexate, vinblastine, doxorubicin, and cisplatin, (MVAC). However, MVAC tends to injure the bone marrow and cause serious infections and sometimes death.
The URMC team investigated the effect of two other chemotherapy drugs, gemcitabine and cisplatin (GC), in a series of 160 patients treated at the Universitys Strong Memorial Hospital from 1999 to 2009, and found that GC is a good substitute with fewer side effects.
Research has shown that in cases of locally advanced disease, giving chemotherapy before surgery can improve a patients outcome. However in practice, many doctors and patients avoid this option due to fear about the rigors of MVAC, particularly since bladder cancer mostly afflicts older people, said Edward M. Messing, M.D., the Winfield W. Scott Chair of the URMC Department of Urology.
With our latest finding, Messing said, we hope pre-surgical chemo will become more acceptable.
In clinical practice, GC is often used in place of MVAC when the bladder cancer has already spread. But researchers wanted to see if the data could be extrapolated to non-metastatic cases.
Therefore, the primary goal of the retrospective cohort study was to determine whether locally advanced tumors treated with GC prior to surgery disappeared entirely or shrank enough to become less threatening and move down to a lower stage.
Of the 160 patients, 25 received pre-surgery GC and 135 did not receive any chemotherapy. Remarkably, in 20 percent of the patients who received chemo (5 people out of 25) the GC treatment entirely eliminated the tumor. In addition, 44 percent of patients experienced shrinkage consistent with a lower stage of cancer, which also gave them a favorable outlook. The pre-surgery GC group was also significantly less likely to have residual invasion of cancer in the nearby tissue and muscle.
Researchers also compared survival in the pre-surgery chemo group to the surgery-only group, for a period of approximately three years. The GC chemo group had fewer deaths (32 percent) than the surgery-only group (43 percent), although the comparison was not precise because the chemo group tended to have people who were younger and with fewer unrelated serious health problems. On the other hand, patients receiving GC usually had more advanced and aggressive cancers.
Messing noted that even when pre-surgery chemo has a positive effect, cancerous tissue can hide deep in the bladder, making removal of the bladder necessary.
Emelian N. Scosyrev, Ph.D., assistant professor of Urology at URMC and the lead author of the study, emphasized that he cannot make any definitive claims about whether GC is equivalent to MVAC, as no one has conducted a prospective, head-to-head comparison of the two chemo regimens in patients with locally advanced bladder cancer.
However, he said, Since both types of chemotherapy are capable of shrinking or eliminating bladder cancer, and since GC is significantly less toxic, we believe our study is an important addition to the literature.
Bladder cancer is common, afflicting about 70,000 people in the United States annually, with men more likely to be diagnosed than women. Median age is 73, according to the National Cancer Institute, and the probability of developing the disease is much higher after age 50. The overall relative five-year survival rate is 78 percent, however, as with all cancers, regional or distance metastasis greatly increases the death rates.
More information: onlinelibrary.wile… SN)1097-0142
Provided by
University of Rochester Medical Center
-
Chemotherapy plus radiation prevents bladder cancer recurrences
Oct 25, 2010 |
not rated yet |
0
-
Gene test shows which bladder cancer patients may have cancer spread
Jan 20, 2011 |
not rated yet |
0
-
New treatment to reduce the relapse rate in bladder cancer patients
Jan 31, 2011 |
not rated yet |
0
-
Characteristics of young age gastric cancer patients
Jan 19, 2010 |
not rated yet |
0
-
Combination therapy spares some head and neck patients from surgery
Jan 19, 2007 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
Scientists put bowel cancer under the microscope
Researchers from London's Kingston University have begun a two-year study which could help prolong the lives of people with colorectal tumours.
Cancer
1 hour ago |
5 / 5 (1) |
0
Researcher identifies breast cancer fighting hormone
Transformative research from Western University has identified new hormones in the body which may suppress breast cancer and stimulate the regression of breast tumors.
Cancer
2 hours ago |
5 / 5 (1) |
0
Ground breaking cancer research finds immune system link
(Medical Xpress)—Curtin University researchers have found evidence that targeting specific cells in the body can reverse the effects of cancer on the immune system.
Cancer
2 hours ago |
5 / 5 (2) |
0
How the EU could help more children survive cancer
A leading expert in childhood cancer at The University of Nottingham is spearheading a Europe-wide lobby of the European Parliament to try to make it easier for doctors to develop and test new treatments on children and young ...
Cancer
3 hours ago |
not rated yet |
0
Study: No higher cancer rate at Conn. Pratt plant
(AP)—Researchers examining the incidence of brain cancer at jet engine manufacturer Pratt & Whitney in Connecticut say they have found no statistically significant elevations in the rate of cancer among workers.
Cancer
4 hours ago |
not rated yet |
0
Saudi to send animal samples to US in coronavirus probe
Saudi Arabia said Friday it would send samples taken from animals possibly infected with a deadly SARS-like virus to the United States for testing in a bid to find the source of disease.
Engineered cytomegalovirus protects monkeys from HIV equivalent
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
New neuron formation could increase capacity for new learning, at the expense of old memories
New research presented today shows that formation of new neurons in the hippocampus - a brain region known for its importance in learning and remembering - could cause forgetting of old memories by causing a reorganization ...
Are there atheists in foxholes? Study says they're the minority
Ernie Pyle – an iconic war correspondent in World War II – reportedly said "There are no atheists in foxholes." A new joint study between two brothers at Cornell and Virginia Wesleyan found that only ...
Help at hand for people with schizophrenia
How can healthy people who hear voices help schizophrenics? Finding the answer for this is at the centre of research conducted at the University of Bergen.
Do doctors understand the individualisation of treatments?
The individualisation of drug treatments to support patients to self-manage their conditions is a concept that sits at the heart of policy, but a recent study in BMJ Open shows that there is no concrete defini ...